ZNF786 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.061640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.553600E-01
Normal-vs-Stage2
7.231800E-02
Normal-vs-Stage3
1.666440E-02
Normal-vs-Stage4
2.613000E-01
Stage1-vs-Stage2
1.709730E-02
Stage1-vs-Stage3
3.142400E-02
Stage1-vs-Stage4
2.805000E-01
Stage2-vs-Stage3
2.214600E-01
Stage2-vs-Stage4
7.014000E-01
Stage3-vs-Stage4
2.079200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.202950E-01
Normal-vs-AfricanAmerican
6.691600E-02
Normal-vs-Asian
1.355210E-01
Caucasian-vs-AfricanAmerican
7.955200E-01
Caucasian-vs-Asian
9.823400E-01
AfricanAmerican-vs-Asian
7.824000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.090850E-01
Normal-vs-Female
1.152210E-01
Male-vs-Female
5.866400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.462200E-01
Normal-vs-Age(41-60Yrs)
2.158800E-01
Normal-vs-Age(61-80Yrs)
6.458000E-02
Normal-vs-Age(81-100Yrs)
2.571800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.686000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.867690E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.811400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.655600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.598200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.889400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.593870E-02
Normal-vs-Daily Drinker
1.086350E-01
Normal-vs-Weekly Drinker
2.073600E-01
Normal-vs-Occasional Drinker
1.889570E-01
Normal-vs-Social Drinker
5.332600E-01
Non Drinker-vs-Daily Drinker
3.277800E-01
Non Drinker-vs-Weekly Drinker
1.814840E-01
Non Drinker-vs-Occasional Drinker
1.835220E-01
Non Drinker-vs-Social Drinker
7.182100E-02
Daily Drinker-vs-Weekly Drinker
6.757600E-01
Daily Drinker-vs-Occasional Drinker
7.121400E-01
Daily Drinker-vs-Social Drinker
2.248200E-01
Weekly Drinker-vs-Occasional Drinker
9.464000E-01
Weekly Drinker-vs-Social Drinker
4.733400E-01
Occasional Drinker-vs-Social Drinker
4.050400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.534000E-01
Normal-vs-Grade 2
1.935770E-01
Normal-vs-Grade 3
2.724800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.078600E-01
Grade 1-vs-Grade 3
6.374000E-01
Grade 1-vs-Grade 4
2.534000E-01
Grade 2-vs-Grade 3
6.867200E-01
Grade 2-vs-Grade 4
1.935770E-01
Grade 3-vs-Grade 4
2.724800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.702400E-02
Normal-vs-NonDiabetic
1.320180E-01
Diabetic-vs-NonDiabetic
4.110000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.328600E-01
Normal-vs-NoPancreatitis
9.193900E-02
Pancreatitis-vs-NoPancreatitis
4.130400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.432440E-01
Normal-vs-N1
6.001800E-02
N0-vs-N1
3.365400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.191430E-01
Normal-vs-TP53-NonMutant
3.916200E-01
TP53-Mutant-vs-TP53-NonMutant
4.013700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
